Peri-scoping the biliary tree reveals stem cell activation in peribiliary glands in primary sclerosing cholangitis

2015 ◽  
Vol 63 (5) ◽  
pp. 1062-1063 ◽  
Author(s):  
Fanyin Meng ◽  
Gianfranco Alpini
2015 ◽  
Vol 63 (5) ◽  
pp. 1220-1228 ◽  
Author(s):  
Guido Carpino ◽  
Vincenzo Cardinale ◽  
Anastasia Renzi ◽  
Johannes R. Hov ◽  
Pasquale Bartolomeo Berloco ◽  
...  

2013 ◽  
Vol 2013 ◽  
pp. 1-5 ◽  
Author(s):  
Yinka K. Davies ◽  
Cynthia J. Tsay ◽  
Dario V. Caccamo ◽  
Kathleen M. Cox ◽  
Ricardo O. Castillo ◽  
...  

Primary sclerosing cholangitis (PSC) is a progressive, cholestatic disease of the liver that is marked by inflammation of the bile ducts and damage to the hepatic biliary tree. Approximately 60–70% of patients also have inflammatory bowel disease and progression of PSC can lead to ulcerative colitis and cirrhosis of the liver. Due to limited understanding of the etiology and mechanism of PSC, the only existing treatment option is orthotopic liver transplantation (OLT); however, recurrence of PSC, after OLT is estimated to be between 5% and 35%. We discuss the successful treatment of a pediatric patient, with recurrent PSC, after OLT with oral Vancomycin.


2015 ◽  
Author(s):  
Udayakumar Navaneethan

Primary sclerosing cholangitis (PSC) is a chronic progressive cholestatic disease characterized by inflammation and fibrosis that may involve the entire biliary tree. The fibrosis causes diffuse narrowing of the intrahepatic and extrahepatic bile ducts, and the resulting biliary stasis leads to secondary biliary cirrhosis and associated complications. This review addresses PSC through its epidemiology, etiopathogenesis, diagnosis, differential diagnosis, management, complications, and prognosis. Figures show pouchoscopy, liver biopsy, and endoscopic retrograde cholangiopancreatography; direct peroral cholangioscopy visualization of cholangiocarcinoma; and algorithms depicting diagnosis of cholangiocarcinoma and screening for inflammatory bowel disease (IBD) in patients with PSC. Tables list characteristics of IBD in PSC, prevalence of antibodies in PSC, differential diagnosis of PSC, diagnostic approach in PSC, and risk of cancers in PSC. This review contains 6 highly rendered figures, 5 tables, and 91 references. 


Hepatology ◽  
2019 ◽  
Vol 71 (3) ◽  
pp. 972-989 ◽  
Author(s):  
Guido Carpino ◽  
Lorenzo Nevi ◽  
Diletta Overi ◽  
Vincenzo Cardinale ◽  
Wei‐Yu Lu ◽  
...  

Hepatology ◽  
2019 ◽  
Vol 69 (2) ◽  
pp. 622-638 ◽  
Author(s):  
Guido Carpino ◽  
Vincenzo Cardinale ◽  
Trine Folseraas ◽  
Diletta Overi ◽  
Krzysztof Grzyb ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document